Our | Products


EMULIMOD





THERAPEUTIC AREA: Neurosciences + Rare Diseases
ACTIVE PRINCIPLE: Fingolimod
PRESENTATION: 0,50 mg x 28 hard capsules
INDICATION:

  • Multiple Sclerosis

COUNTRIES WHERE IT IS MARKETED:
Argentina